Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

67.73
-2.4100-3.44%
Pre-market: 68.450.7200+1.06%08:45 EDT
Volume:5.15M
Turnover:350.30M
Market Cap:8.35B
PE:18.02
High:69.85
Open:69.85
Low:67.13
Close:70.14
Loading ...

Halozyme Therapeutics, Inc : Morgan Stanley Raises Target Price to $73.00 From $67.00

THOMSON REUTERS
·
Yesterday

William O'Neil Initiates Halozyme Therapeutics at Buy

MT Newswires Live
·
Yesterday

Halozyme Therapeutics Up Over 17%, on Track for Record High Close -- Data Talk

Dow Jones
·
Yesterday

Halozyme Therapeutics Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
07 May

Stock Track | Halozyme Therapeutics Soars 8.33% Following Analyst Price Target Hikes

Stock Track
·
07 May

Stock Track | Halozyme Therapeutics Soars 6.77% Pre-market on Analyst Price Target Hikes

Stock Track
·
07 May

Morgan Stanley Raises Price Target on Halozyme Therapeutics to $73 From $67, Keeps Overweight Rating

MT Newswires Live
·
07 May

Wells Fargo Sticks to Its Hold Rating for Halozyme (HALO)

TIPRANKS
·
07 May

Halozyme Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Stock Track | Halozyme Therapeutics Soars 6.10% After-Hours on Strong Q1 Results and Raised 2025 Guidance

Stock Track
·
07 May

Halozyme Therapeutics Q1 Adjusted EPS, Revenue Increase, Boosts 2025 Outlook; Shares Rise

MT Newswires Live
·
07 May

Halozyme Therapeutics Q1 Adj. EPS $1.11 Beats $0.94 Estimate, Sales $264.86M Beat $230.18M Estimate

Benzinga
·
07 May

BRIEF-Halozyme Therapeutics Q1 Adjusted EPS USD 1.11 Vs. IBES Estimate USD 0.94

Reuters
·
07 May

Halozyme Therapeutics Inc - Announces New $250 Million Share Repurchase

THOMSON REUTERS
·
07 May

Halozyme Therapeutics Inc FY2025 Shr View $5.00, REV View $1.20 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
07 May

Halozyme Therapeutics Inc - Non-Gaap 2025 EPS Guidance Raised to $5.30-$5.70

THOMSON REUTERS
·
07 May

Halozyme Raises 2025 Financial Guidance Ranges and Reports Strong First Quarter 2025 Results

THOMSON REUTERS
·
07 May

Halozyme to Participate in the BofA Securities 2025 Healthcare Conference

PR Newswire
·
06 May

Halozyme Therapeutics Inc. Concluded Annual Meeting of Stockholders

Reuters
·
03 May

Techne (TECH) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
30 Apr